Diversify Wealth Management LLC Has $1.47 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Diversify Wealth Management LLC increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 7.3% in the third quarter, Holdings Channel reports. The institutional investor owned 13,909 shares of the medical device company’s stock after buying an additional 941 shares during the period. Diversify Wealth Management LLC’s holdings in Cooper Companies were worth $1,465,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Covestor Ltd raised its position in Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Innealta Capital LLC acquired a new position in Cooper Companies during the second quarter valued at approximately $25,000. Crewe Advisors LLC raised its position in Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after purchasing an additional 252 shares in the last quarter. Clearstead Trust LLC acquired a new position in Cooper Companies during the first quarter valued at approximately $36,000. Finally, Tortoise Investment Management LLC raised its position in Cooper Companies by 75.4% during the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after purchasing an additional 169 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on COO. Robert W. Baird boosted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Morgan Stanley boosted their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $105.20 on Thursday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a twelve month low of $77.01 and a twelve month high of $112.38. The stock has a market cap of $20.95 billion, a price-to-earnings ratio of 58.44, a P/E/G ratio of 2.53 and a beta of 0.98. The company’s fifty day moving average is $106.34 and its 200 day moving average is $96.91.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.84 earnings per share. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.